Andrew T. Drechsler

This profile gathers the share dealings of Andrew T. Drechsler across 4 companies, led by INSMED Inc, Provention Bio, Inc. and Baudax Bio, Inc. Over a trading history stretching from 2 February 2006 to 15 June 2022, the count stands at 17 filings.

Both buying and selling appear: 4 purchases worth €72k, against 3 sales worth €922k. Netting one side against the other leaves €850k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 3 share grants and 6 option exercises.

In size, the median ticket on the buying side is €20k. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The latest filing, published on 17 June 2022, reports a share grant in Baudax Bio, Inc. The latest purchase dates back some time: it was published 2,243 days ago, on 2 September 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.